Heart Health Support
Support for healthy heart function, cardiovascular performance, and long-term cardiac wellness.
TL;DR
Cardiovascular risk is driven by apoB-containing lipoproteins, blood pressure, glucose control and smoking. Supplements play a supporting role: omega-3 at high dose lowers triglycerides, red yeast rice and plant sterols lower LDL modestly, and CoQ10 has trial support in heart failure.
Why It Matters
The causal drivers are well established. LDL/apoB lowering reduces events proportionally to the absolute reduction achieved; blood pressure reduction of 10 mmHg systolic cuts major cardiovascular events by roughly 20%. Among supplements, EPA at 4 g/day (icosapent ethyl in REDUCE-IT) reduced events in high-risk patients with elevated triglycerides, plant sterols lower LDL by 5-15%, red yeast rice contains monacolin K (chemically identical to lovastatin, with the same muscle and liver considerations and variable product content), and CoQ10 improved outcomes in the Q-SYMBIO heart failure trial. None replace statin therapy where indicated.
How to Measure
Full lipid panel including apoB and, once in a lifetime, Lp(a). Blood pressure by validated home monitor averaged over 7 days, not a single clinic reading. HbA1c, hs-CRP, renal function and a 10-year risk calculation (QRISK3, ASCVD or SCORE2). Coronary artery calcium scoring can reclassify risk in intermediate-risk adults.
Biomarkers
Target Ranges
apoB
<80 mg/dL (<65 if high risk)
LDL-C
<100 mg/dL (<70 if high risk)
Triglycerides
<150 mg/dL
Home blood pressure
<135/85 mmHg average
Lp(a)
<50 mg/dL (measure once)
hs-CRP
<1.0 mg/L
Optimization Protocol
Non-negotiables: stop smoking, 150 minutes weekly of moderate aerobic activity, Mediterranean dietary pattern, sodium under 2 g/day, alcohol moderation, and treat hypertension and dyslipidaemia to guideline targets with your clinician. Supplement layer: omega-3 2-4 g EPA+DHA daily for triglycerides above 200 mg/dL; plant sterols/stanols 2 g daily with meals for a 5-15% LDL reduction; CoQ10 100-300 mg daily as an adjunct in heart failure with reduced ejection fraction. Red yeast rice needs the same monitoring as a statin and should not be combined with one. Do not substitute any of these for prescribed therapy.
Lifestyle Levers
- •Complete smoking cessation
- •150+ minutes weekly aerobic exercise
- •Mediterranean or DASH dietary pattern
- •Sodium below 2 g daily
- •Weight management
- •Alcohol moderation
- •Sleep apnoea treatment
- •Stress and blood pressure management
Supporting Supplements
Krill Oil
Better absorbed, worse value. Sound for general omega-3 status if fish oil causes reflux; the wrong tool if you need therapeutic doses for high triglycerides.
Magnesium
Magnesium supports vascular tone and rhythm; deficiency correction has clear cardiovascular rationale.
Taurine
Taurine lowers blood pressure modestly and improved exercise capacity in heart failure trials, an underrated cardiovascular profile.
Omega-3 Fatty Acids
Strong cardiovascular case: meaningful triglyceride and event-reduction data, especially for EPA.
Vitamin K2
Observational data linking K2 to less arterial calcification is promising, but randomised trials have not confirmed clinical benefit.
CoQ10
Strong support for heart health, especially in heart failure, hypertension and statin users.
Spermidine
Cardioprotection is compelling in mice and suggestive in cohort data only.
Calcium
Calcium supplements do not benefit the heart and may modestly raise cardiovascular risk at high supplemental doses.
Resveratrol
Modest cardiometabolic changes appear in some trials but do not consistently reach clinical significance.
Vitamin B1 (Thiamine)
Thiamine may help heart failure patients with deficiency, often diuretic-induced, but general cardiovascular benefit is unproven.
Pterostilbene
One human trial found lipid and blood pressure changes, though LDL rose at higher doses.
L-Carnitine
L-carnitine improved outcomes after myocardial infarction in older pooled analyses, but concerns about TMAO production complicate the picture.
Quercetin
Quercetin produces small reductions in blood pressure in meta-analysis, most evident at doses above 500mg daily and in people with hypertension. Effects on lipids and clinical events are unproven.
Vitamin E
Large randomised trials consistently show no cardiovascular benefit from vitamin E supplementation.
Betaine (TMG)
Betaine lowers homocysteine, but higher doses can raise LDL cholesterol, muddying the cardiovascular picture.
Supporting Research
Frequently Asked Questions
Typical Timeframe
Lipid changes are measurable at 6-8 weeks. Blood pressure responds to sodium and exercise changes in 2-4 weeks. Triglycerides fall within 4-8 weeks on high-dose omega-3. Event-level risk reduction accrues over years.
Research Summary
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.